Opportunity
SAM #75F40126Q131706
FDA Solicits Solubility Testing System for Drug Evaluation Research
Buyer
FDA Office of the Associate General Counsel for Administrative Law
Posted
August 12, 2026
Respond By
August 17, 2026
Identifier
75F40126Q131706
NAICS
334516
The U.S. Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER), Office of Pharmaceutical Quality (OPQ), is seeking to procure a Solubility Testing System to support drug evaluation and research. - Government Buyer: - U.S. Food and Drug Administration (FDA) - Center for Drug Evaluation and Research (CDER) - Office of Pharmaceutical Quality (OPQ) - Products/Services Requested: - One (1) Solubility Testing System - Must provide sample temperature control at 37°C - Adjustable stirring speed and multiple simultaneous sample containers - Sample withdrawal at different time points - In-line filtering or centrifugation - Optional dilution, pH monitoring, and HPLC connectivity - Includes at least one-year warranty, delivery, installation, and on-site training for at least 6 scientists - Must support network computer connectivity - Unique/Notable Requirements: - Delivery, installation, and training must be included - Firm-fixed price contract; no advance payments - Quotes must remain valid through the specified period - System must be delivered to FDA/CDER - No specific OEMs or vendors are named in the solicitation - All technical requirements are clearly defined to ensure suitability for biopharmaceutics classification and bioequivalence studies
Description
See Attached Combined Synopsis/Solicitation 75F40126Q131706